It is a trading private limited company based in Kolkata, West Bengal, India, established in 2019.
2019 | Kolkata, West Bengal, India | ActiveErica Drugs Private Limited, a active private limited company, was established on 18 November 2019 in Kolkata, West Bengal, India. Engaging in specialty within the trading sector, it holds CIN: U51909WB2019PTC234795. Registered under ROC Roc Kolkata. it is unlisted. It has an authorized capital of ₹3.50 M and a paid-up capital of ₹2.75 M.
Its leadership includes Chhayarani Samanta (Director), Kajal Kumar Samanta (Director), Ruma Mukherjee (Director). Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 2Q, Bediadanga 2Nd Lane, Tiljala, Kolkata, West Bengal, 700039.
U51909WB2019PTC234795
234795
18 November 2019
₹3.50 M
₹2.75 M
Roc Kolkata
Unlisted
Active
Explore comprehensive insights into Erica Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Chhayarani Samanta | Director | 18 Nov 2019 | Current |
| Kajal Kumar Samanta | Director | 18 Nov 2019 | Current |
| Ruma Mukherjee | Director | 18 Nov 2019 | Current |
| Shantanu Mukherjee | Additional Director | 30 Oct 2021 | Current |
| Animesh Aich | Additional Director | 30 Oct 2021 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Erica Drugs's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Erica Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Erica Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Erica Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Erica Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Erica Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Erica Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kolkata. was recorded as a recent event.
Shantanu Mukherjee was appointed as a Additional Director was appointed as a Additional Director on 30 Oct 2021 & has been associated with this company since 4 years 2 months . was recorded as a recent event.
Progress on Animesh Aich was appointed as a Additional Director was appointed as a Additional Director on 30 Oct 2021 & has been associated with this company since 4 years 2 months . was documented.
Chhayarani Samanta was appointed as a Director was appointed as a Director on 18 Nov 2019 & has been associated with this company since 6 years 1 month . was recorded as a recent event.
Progress on Kajal Kumar Samanta was appointed as a Director was appointed as a Director on 18 Nov 2019 & has been associated with this company since 6 years 1 month . was documented.
The CIN of Erica Drugs Private Limited is U51909WB2019PTC234795.
Erica Drugs Private Limited is headquartered at 2Q, Bediadanga 2Nd Lane, Tiljala, Kolkata, West Bengal, 700039.
Erica Drugs Private Limited was incorporated on 18 November 2019.
The current directors of Erica Drugs Private Limited are
The primary industry of Erica Drugs Private Limited is Trading.
Erica Drugs Private Limited is unlisted.
The authorized capital of Erica Drugs Private Limited is ₹3.50 M, and the paid-up capital is ₹2.75 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX